Prova Storytel gratis i 30 dagar Ett universum fyllt av ljudböcker, klicka här för att komma igång

e-ESO Podcasts

En podcast av: ESO - European School of Oncology

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www

Our American listeners can also listen to e-ESO Podcasts at our American site

143 Avsnitt

Angiosarcoma Essentials
Publicerades 2024-12-18

The Lines of Therapy After Progression on CDK4/6 Inhibitors Plus Endocrine Therapy to Overcome the Resistance in HR+/Her2 - Metastatic Breast Cancer Patients
Publicerades 2024-12-12
Women’s Health Frontiers: Breakthroughs from ESMO 2024
Publicerades 2024-11-28
ESMO Congress Prostate Cancer Highlights
Publicerades 2024-11-14
How to interpret prognostic models papers in hematology and oncology
Publicerades 2024-10-31
Stage III Lung Cancer Resecability
Publicerades 2024-10-17
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline
Publicerades 2024-10-03
Clinical approach and therapeutic overview on gastroenteropancreatic neoendocrine tumours (GEP-NENS)
Publicerades 2024-09-19
Fear of recurrence: one of the major elements in reactivating cancer
Publicerades 2024-07-25
Immunohistochemistry in oncology
Publicerades 2024-07-11
Thrombosis and cachexia in cancer: Two partners in crime?
Publicerades 2024-06-13
From clinical and academic culture in radiation oncology - how to cross the chasm?
Publicerades 2024-05-30
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer
Publicerades 2024-05-16
Approach to severe immune-related adverse events: beyond corticosteroids and other challenges
Publicerades 2024-04-30
Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors
Publicerades 2024-04-18
The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer
Publicerades 2024-04-04
Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value
Publicerades 2024-03-20
An inter-specialty cancer training programme curriculum for Europe
Publicerades 2024-03-07
Communicating the oncological diagnosis: a psycho-oncological perspective
Publicerades 2024-02-22
ESMO 2023 Highlights on lung cancer
Publicerades 2024-02-08

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

143 Avsnitt

Angiosarcoma Essentials

The Lines of Therapy After Progression on CDK4/6 Inhibitors Plus Endocrine Therapy to Overcome the Resistance in HR+/Her2 - Metastatic Breast Cancer Patients

Women’s Health Frontiers: Breakthroughs from ESMO 2024

ESMO Congress Prostate Cancer Highlights

How to interpret prognostic models papers in hematology and oncology

Stage III Lung Cancer Resecability

Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline

Clinical approach and therapeutic overview on gastroenteropancreatic neoendocrine tumours (GEP-NENS)

Fear of recurrence: one of the major elements in reactivating cancer

Immunohistochemistry in oncology

Thrombosis and cachexia in cancer: Two partners in crime?

From clinical and academic culture in radiation oncology - how to cross the chasm?

Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

Approach to severe immune-related adverse events: beyond corticosteroids and other challenges

Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors

The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer

Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value

An inter-specialty cancer training programme curriculum for Europe

Communicating the oncological diagnosis: a psycho-oncological perspective

ESMO 2023 Highlights on lung cancer